See more : Taj Systems, Inc. (TJSS) Income Statement Analysis – Financial Results
Complete financial analysis of Natural Health Trends Corp. (NHTC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Natural Health Trends Corp., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
You may be interested
- GLOME Holdings,Inc. (8938.T) Income Statement Analysis – Financial Results
- Compañía Sud Americana de Vapores S.A. (VAPORES.SN) Income Statement Analysis – Financial Results
- The Greenrose Holding Company Inc. (GNRSU) Income Statement Analysis – Financial Results
- Yuanda China Holdings Limited (2789.HK) Income Statement Analysis – Financial Results
- Lotus Technology Inc. American Depositary Shares (LOT) Income Statement Analysis – Financial Results
Natural Health Trends Corp. (NHTC)
About Natural Health Trends Corp.
Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also provides beauty products, such as age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the company offers home appliances; daily products, such as oral care, hair care, and body care; and home appliances products. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Tsim Sha Tsui, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.92M | 49.13M | 60.01M | 62.07M | 77.61M | 191.91M | 197.56M | 287.73M | 264.86M | 124.59M | 52.53M | 37.51M | 31.16M | 23.58M | 30.74M | 45.81M | 76.50M | 133.43M | 194.47M | 133.23M | 62.89M | 39.66M | 24.79M | 8.32M | 15.27M | 1.19M | 6.99M | 7.22M |
| Cost of Revenue | 11.18M | 12.66M | 15.01M | 16.99M | 20.10M | 39.37M | 38.65M | 54.90M | 54.10M | 26.98M | 12.55M | 9.69M | 8.17M | 6.97M | 9.53M | 12.68M | 20.29M | 33.07M | 44.75M | 29.32M | 12.52M | 7.39M | 5.88M | 2.05M | 4.27M | 454.37K | 2.87M | 4.44M |
| Gross Profit | 32.75M | 36.47M | 45.00M | 45.08M | 57.51M | 152.54M | 158.92M | 232.83M | 210.76M | 97.61M | 39.98M | 27.83M | 22.99M | 16.61M | 21.21M | 33.13M | 56.21M | 100.36M | 149.73M | 103.90M | 50.36M | 32.27M | 18.92M | 6.27M | 11.00M | 736.75K | 4.12M | 2.78M |
| Gross Profit Ratio | 74.56% | 74.23% | 74.99% | 72.63% | 74.10% | 79.49% | 80.44% | 80.92% | 79.57% | 78.34% | 76.11% | 74.18% | 73.78% | 70.44% | 69.01% | 72.32% | 73.48% | 75.22% | 76.99% | 77.99% | 80.08% | 81.36% | 76.30% | 75.41% | 72.06% | 61.85% | 58.98% | 38.46% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.01M | 16.00M | 17.85M | 18.21M | 27.22M | 31.31M | 31.69M | 43.25M | 36.02M | 19.69M | 11.63M | 9.42M | 9.05M | 9.80M | 13.89M | 17.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.64M | 18.46M | 7.72M | 3.28M | 7.64M | 3.41M |
| Selling & Marketing | 18.41M | 20.75M | 25.58M | 26.20M | 35.55M | 87.50M | 115.32M | 168.30M | 162.62M | 76.68M | 35.69M | 25.14M | 11.86M | 8.67M | 11.60M | 17.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 34.42M | 36.74M | 43.42M | 44.41M | 62.77M | 118.81M | 115.32M | 168.30M | 162.62M | 76.68M | 35.69M | 25.14M | 20.91M | 18.47M | 25.48M | 34.82M | 69.62M | 114.00M | 152.78M | 101.68M | 43.84M | 28.77M | 17.64M | 18.46M | 7.72M | 3.28M | 7.64M | 3.41M |
| Other Expenses | 0.00 | 872.00K | -61.00K | 821.00K | 1.43M | 789.00K | 367.00K | -59.00K | -84.00K | -184.00K | -32.00K | -39.00K | 298.00K | 1.21M | 1.32M | 1.46M | 11.82M | -1.41M | 59.03M | 39.26M | -50.00M | 0.00 | 0.00 | 0.00 | 10.40M | 0.00 | 543.21K | 22.00K |
| Operating Expenses | 34.42M | 36.74M | 43.42M | 44.41M | 62.77M | 118.81M | 115.86M | 168.69M | 162.89M | 76.79M | 35.75M | 25.18M | 21.21M | 19.69M | 26.80M | 36.28M | 81.44M | 112.60M | 152.78M | 101.68M | -6.16M | 28.77M | 17.64M | 18.46M | 18.12M | 3.28M | 8.18M | 3.43M |
| Cost & Expenses | 45.60M | 49.40M | 58.43M | 61.40M | 82.87M | 158.18M | 154.50M | 223.59M | 216.98M | 103.77M | 48.30M | 34.87M | 29.38M | 26.66M | 36.33M | 48.96M | 101.73M | 145.66M | 197.53M | 131.00M | 6.36M | 36.16M | 23.51M | 20.51M | 22.39M | 3.73M | 11.05M | 7.88M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00K | 9.00K | 36.00K | 107.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.00K | 18.00K | 2.55M | 2.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.10M | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 164.00K | 1.38M | 1.46M | 1.94M | 2.15M | 424.00K | 536.00K | 394.00K | 263.00K | 105.00K | 66.00K | 45.00K | 298.00K | 1.21M | 1.32M | 1.46M | 1.85M | 2.11M | 1.47M | 1.30M | 531.94K | 469.70K | 90.58K | 364.40K | 374.15K | 549.67K | 567.67K | 244.57K |
| EBITDA | -1.51M | -66.00K | 1.87M | 1.08M | -4.87M | 34.16M | 43.60M | 64.53M | 48.14M | 20.93M | 4.29M | 2.69M | 2.08M | -1.28M | -2.59M | 472.00K | -23.37M | -10.12M | -1.83M | 3.52M | 6.11M | 437.00K | 1.37M | -11.82M | -6.74M | -1.99M | -3.41M | -413.86K |
| EBITDA Ratio | -3.43% | -0.13% | 3.12% | 1.74% | -4.00% | 17.80% | 22.07% | 22.43% | 18.18% | 16.80% | 8.17% | 7.17% | 6.69% | -7.88% | -13.77% | -3.47% | -15.13% | -8.49% | -0.24% | 2.48% | 90.63% | 7.76% | 5.65% | -142.21% | -43.72% | -167.12% | -48.73% | -5.73% |
| Operating Income | -1.67M | -270.00K | 1.57M | 669.00K | -5.26M | 33.73M | 43.06M | 64.14M | 47.88M | 20.82M | 4.22M | 2.65M | 1.78M | -3.08M | -5.59M | -3.18M | -25.22M | -12.23M | -3.05M | 2.22M | 56.52M | 3.50M | 1.28M | -12.55M | -7.12M | -2.54M | -4.06M | -658.43K |
| Operating Income Ratio | -3.80% | -0.55% | 2.62% | 1.08% | -6.78% | 17.58% | 21.80% | 22.29% | 18.08% | 16.71% | 8.04% | 7.05% | 5.72% | -13.06% | -18.18% | -6.95% | -32.97% | -9.17% | -1.57% | 1.67% | 89.88% | 8.83% | 5.17% | -150.86% | -46.61% | -213.27% | -58.00% | -9.12% |
| Total Other Income/Expenses | 2.42M | 872.00K | -61.00K | 821.00K | 1.43M | 789.00K | 367.00K | -59.00K | -84.00K | -184.00K | -32.00K | -39.00K | 344.00K | 583.00K | -875.00K | -226.00K | 143.00K | 946.00K | -277.00K | 137.00K | -1.00K | -199.00K | -79.95K | 9.08K | -67.18K | 1.25M | -1.14M | -231.11K |
| Income Before Tax | 745.00K | 602.00K | 1.51M | 1.49M | -5.60M | 34.52M | 43.43M | 64.08M | 47.79M | 20.64M | 4.19M | 2.61M | 2.13M | -2.50M | -6.46M | -3.41M | -25.08M | -11.29M | -3.96M | 2.36M | 6.24M | 4.10M | 1.20M | -10.67M | -7.25M | -1.29M | -5.20M | -889.54K |
| Income Before Tax Ratio | 1.70% | 1.23% | 2.52% | 2.40% | -7.21% | 17.99% | 21.98% | 22.27% | 18.04% | 16.56% | 7.98% | 6.95% | 6.83% | -10.59% | -21.02% | -7.44% | -32.79% | -8.46% | -2.04% | 1.77% | 9.92% | 10.34% | 4.85% | -128.24% | -47.50% | -108.13% | -74.37% | -12.32% |
| Income Tax Expense | 177.00K | 289.00K | 425.00K | 647.00K | 14.00K | 3.49M | 19.85M | 8.99M | 552.00K | 266.00K | 102.00K | -24.00K | -298.00K | -27.00K | -78.00K | 456.00K | 200.00K | 182.00K | 1.59M | 663.00K | 860.00K | -4.10M | -1.20M | 10.67M | 7.25M | 1.29M | 2.52M | 231.11K |
| Net Income | 568.00K | 313.00K | 1.09M | 843.00K | -5.61M | 31.04M | 23.58M | 55.09M | 47.24M | 20.37M | 4.09M | 2.63M | 2.31M | -2.45M | -6.34M | -3.86M | -25.29M | -11.46M | -5.50M | 1.24M | 5.38M | 4.10M | 1.20M | -10.67M | -7.25M | -1.29M | -7.73M | -889.54K |
| Net Income Ratio | 1.29% | 0.64% | 1.81% | 1.36% | -7.23% | 16.17% | 11.93% | 19.15% | 17.84% | 16.35% | 7.78% | 7.01% | 7.40% | -10.38% | -20.63% | -8.44% | -33.05% | -8.59% | -2.83% | 0.93% | 8.55% | 10.34% | 4.85% | -128.24% | -47.50% | -108.13% | -110.48% | -12.32% |
| EPS | 0.05 | 0.03 | 0.10 | 0.08 | -0.52 | 2.75 | 2.10 | 4.84 | 3.84 | 1.67 | 0.36 | 0.24 | 0.21 | -0.23 | -0.63 | -0.40 | -2.96 | -1.42 | -0.79 | 0.22 | 1.03 | 0.60 | 0.44 | -111.27 | -100.28 | -58.27 | -805.12 | -317.35 |
| EPS Diluted | 0.05 | 0.03 | 0.10 | 0.07 | -0.52 | 2.74 | 2.09 | 4.83 | 3.82 | 1.61 | 0.36 | 0.23 | 0.21 | -0.23 | -0.63 | -0.40 | -2.96 | -1.42 | -0.79 | 0.18 | 0.83 | -11.00 | -98.00 | -111.27 | -100.28 | -58.27 | -805.12 | -317.35 |
| Weighted Avg Shares Out | 11.44M | 11.36M | 11.02M | 10.63M | 10.87M | 11.30M | 11.25M | 11.38M | 12.30M | 12.13M | 11.15M | 10.94M | 10.70M | 10.51M | 10.14M | 9.68M | 8.56M | 8.08M | 6.93M | 5.58M | 4.61M | 2.90M | 1.07M | 95.89K | 72.33K | 22.10K | 9.60K | 2.80K |
| Weighted Avg Shares Out (Dil) | 11.46M | 11.42M | 11.42M | 11.42M | 10.87M | 11.32M | 11.27M | 11.41M | 12.37M | 12.60M | 11.33M | 11.23M | 10.83M | 10.51M | 10.14M | 9.68M | 8.56M | 8.08M | 6.93M | 6.82M | 5.69M | 2.90M | 1.07M | 95.89K | 72.33K | 22.10K | 9.60K | 2.80K |
Home, sweet home! - Visually impaired man seizes chance at independence
“Oh, gosh! I’m blown away!” were the first words uttered by Mark Sweeney shortly after he was presented with the keys to and documents for his new home. Two hundred homes were handed over at SilverSun Estate in St Catherine...
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-Small Cell Lung Cancer and Metastatic Castration-Resistant Prostate Cancer
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and participate in the
Natural Health Trends' (NHTC) Management on Q1 2020 Results - Earnings Call Transcript
Natural Health Trends Corp. (NASDAQ:NHTC) Q1 2020 Earnings Conference Call May 6, 2020 11:30 AM ET Company Participants Kim Orlando – Investor Relations Chris S
Charlotte's Web (CWEB) 4Q Earnings Big Miss | Grizzle
Charlotte's Web (TSE: CWEB) posted disappointing earnings. Competition is fierce and the company's refusal to drop prices is hurting sales.
The Account and my First Trade
Current Account Size As of 12/11/16, the brokerage account that I will track on this blog currently has a balance of $51,121.23. The broker I am using is TD Ameritrade. I used Ameritrade in the p…
Source: https://incomestatements.info
Category: Stock Reports